January 31, 2019 / 7:21 AM / 3 months ago

BRIEF-Roche CEO sees similar biosimilar impact on Rituxan in 2019 - CNBC

Jan 31 (Reuters) - Roche Holding AG:

* CEO SAYS SEES CONTINUED STRONG MOMENTUM WITH NEW DRUGS, CONFIDENT CAN OFFSET ENTRY OF BIOSIMILAR DRUGS IN EUROPE - CNBC

* CEO SAYS SEES SIMILAR IMPACT FROM BIOSIMILARS ON RITUXAN IN 2019 - CNBC Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below